Rock Springs Capital Management LP Q3 2023 Filing
Filed November 14, 2023
Portfolio Value
$3.7B
Holdings
120
Report Date
Q3 2023
Filing Type
13F-HR
All Holdings (120 positions)
| Stock | Value |
|---|---|
GOSS 5 06/01/27GOSSAMER BIO INC | $3.0B |
HUMHUMANA INC | $212.0M |
OVASUSDTEMPEST THERAPEUTICS INC | $163.4M |
IMCRIMMUNOCORE HLDGS PLC | $152.0M |
AGLAGILON HEALTH INC | $147.0M |
NBIXNEUROCRINE BIOSCIENCES INC | $139.0M |
2L9BLUEPRINT MEDICINES CORP | $134.0M |
ARGXARGENX SE | $127.0M |
PENPENUMBRA INC | $121.0M |
EVHEVOLENT HEALTH INC | $105.0M |
BCELATRECA INC | $94.6M |
ISRGINTUITIVE SURGICAL INC | $87.0M |
KRTXKARUNA THERAPEUTICS INC | $85.0M |
IDXXIDEXX LABS INC | $85.0M |
SGENUSDSEAGEN INC | $84.0M |
WSTWEST PHARMACEUTICAL SVSC INC | $75.0M |
AKROAKERO THERAPEUTICS INC | $71.0M |
EXASEXACT SCIENCES CORP | $69.0M |
AGIOAGIOS PHARMACEUTICALS INC | $67.0M |
AFWALIGN TECHNOLOGY INC | $66.0M |
ACHCACADIA HEALTHCARE COMPANY IN | $63.0M |
BSXBOSTON SCIENTIFIC CORP | $61.0M |
PODDINSULET CORP | $60.0M |
MIRMMIRUM PHARMACEUTICALS INC | $57.0M |
CERE1EURCEREVEL THERAPEUTICS HLDNG I | $55.0M |
DC4DEXCOM INC | $54.0M |
RAREULTRAGENYX PHARMACEUTICAL IN | $52.0M |
ALNYALNYLAM PHARMACEUTICALS INC | $49.0M |
MRTXEURMIRATI THERAPEUTICS INC | $49.0M |
SRPTSAREPTA THERAPEUTICS INC | $47.0M |
EWEDWARDS LIFESCIENCES CORP | $44.0M |
FRPTFRESHPET INC | $43.0M |
XENEXENON PHARMACEUTICALS INC | $40.0M |
ASNDASCENDIS PHARMA A/S | $39.0M |
RYTMRHYTHM PHARMACEUTICALS INC | $36.0M |
PHRPHREESIA INC | $33.0M |
IRTCIRHYTHM TECHNOLOGIES INC | $33.0M |
PCRXPACIRA BIOSCIENCES INC | $32.0M |
ZLABZAI LAB LTD | $30.0M |
ACCDEURACCOLADE INC | $30.0M |
LEGNLEGEND BIOTECH CORP | $30.0M |
SWAVUSDSHOCKWAVE MED INC | $29.0M |
HZNPHORIZON THERAPEUTICS PUB L | $29.0M |
PRTAPROTHENA CORP PLC | $29.0M |
—ABCAM PLC | $28.0M |
MDGLMADRIGAL PHARMACEUTICALS INC | $28.0M |
AMLXAMYLYX PHARMACEUTICALS INC | $28.0M |
ACRSACLARIS THERAPEUTICS INC | $27.0M |
DVAXDYNAVAX TECHNOLOGIES CORP | $26.0M |
LFSTLIFESTANCE HEALTH GROUP INC | $25.0M |
XLVSELECT SECTOR SPDR TR | $25.0M |
—OLINK HLDG AB | $24.0M |
IMVTIMMUNOVANT INC | $24.0M |
BMRNBIOMARIN PHARMACEUTICAL INC | $23.0M |
AZTAAZENTA INC | $23.0M |
NVROEURNEVRO CORP | $23.0M |
IMTXIMMATICS N.V | $21.0M |
WRBYWARBY PARKER INC | $20.0M |
KYMRKYMERA THERAPEUTICS INC | $20.0M |
RVMDREVOLUTION MEDICINES INC | $20.0M |
MRUSMERUS N V | $19.0M |
BCRXBIOCRYST PHARMACEUTICALS INC | $18.0M |
AMGNAMGEN INC | $18.0M |
IRONDISC MEDICINE INC | $17.0M |
TVTXTRAVERE THERAPEUTICS INC | $16.0M |
INZYINOZYME PHARMA INC | $15.0M |
NUVB/WSNUVATION BIO INC | $13.4M |
TCE2CELLDEX THERAPEUTICS INC NEW | $13.0M |
AM6AMICUS THERAPEUTICS INC | $12.0M |
COLLCOLLEGIUM PHARMACEUTICAL INC | $12.0M |
IMGNEURIMMUNOGEN INC | $12.0M |
ABOSACUMEN PHARMACEUTICALS INC | $11.0M |
MLYSMINERALYS THERAPEUTICS INC | $11.0M |
CMPXCOMPASS THERAPEUTICS INC | $10.0M |
KRYSKRYSTAL BIOTECH INC | $10.0M |
MREOMEREO BIOPHARMA GROUP PLC | $9.0M |
EDAEDAP TMS S A | $9.0M |
OKURRENEO PHARMACEUTICALS INC | $8.0M |
INSPINSPIRE MED SYS INC | $8.0M |
PLRXPLIANT THERAPEUTICS INC | $8.0M |
LUNGPULMONX CORP | $6.0M |
SPRBSPRUCE BIOSCIENCES INC | $6.0M |
SGMTSAGIMET BIOSCIENCES INC | $6.0M |
—ICOSAVAX INC | $6.0M |
AURAAURA BIOSCIENCES INC | $6.0M |
MGNXMACROGENICS INC | $5.0M |
RLAYRELAY THERAPEUTICS INC | $5.0M |
—MERSANA THERAPEUTICS INC | $4.0M |
NVV1NOVAVAX INC | $4.0M |
AUPHAURINIA PHARMACEUTICALS INC | $3.0M |
FULCFULCRUM THERAPEUTICS INC | $3.0M |
HCATHEALTH CATALYST INC | $3.0M |
CYTKCYTOKINETICS INC | $3.0M |
XLOXILIO THERAPEUTICS INC | $3.0M |
TVTX 2.5 09/15/25TRAVERE THERAPEUTICS INC | $2.0M |
BEAMBEAM THERAPEUTICS INC | $2.0M |
VIGLVIGIL NEUROSCIENCE INC | $2.0M |
BMEABIOMEA FUSION INC | $2.0M |
ADAPYADAPTIMMUNE THERAPEUTICS PLC | $2.0M |
EPIEURESSA PHARMA INC | $2.0M |
Page 1 of 2Next